Open access
Open access
Powered by Google Translator Translator

RCT | Simvastatin is ineffective as a disease-modifying treatment for patients with Parkinson’s Disease.

23 Nov, 2022 | 13:42h | UTC

Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease: A Randomized Clinical Trial – JAMA Neurology

Commentary: Simvastatin Ineffective as Disease-Modifying Therapy for Intermediate Parkinson Disease – AJMC

 

Commentary on Twitter

 


Stay Updated in Your Specialty

No spam, just news.